Please login to the form below

Not currently logged in

Shires's Jeffrey Jonas to lead Sage

CNS appoints CEO alongside new CMO and CFO

Jeffrey Jones, Sage TherapeuticsSage Therapeutics has made several changes at the top level, including the appointment of Shire's Dr Jeffrey Jonas as CEO.

The other key appointments are AstraZeneca's Stephen Kanes as chief medical officer and Santhera's Kimi Iguchi as chief financial officer.

The changes come two years after the formation of the central nervous system (CNS) specialist and signal the expected growth of Sage as it moves its research programmes into late-stage development.

This will be headed by Dr Jonas (pictured), who was president of regenerative medicines at Shire and has a career in the life sciences that spans more than 20 years and includes CNS experience.

His roles prior to joining Shire include serving as executive VP of Isis Pharmaceuticals and chief medical officer of Forest Laboratories.

Dr Jonas also has entrepreneurial experience, founding Avax technologies and Sceptor Industries.

His new colleagues include Dr Kanes, who was most recently executive director/ therapeutic area clinical director for the inflammation, neuroscience and respiratory GMED division of AZ.

Dr Kanes also has experience as a faculty member in the psychiatry department at the University of Pennsylvania School of Medicine

Iguchi joins from her role as chief operating officer, North America, for Santhera.

Her previous positions include VP, finance, for Cyberkinetics Neurotechnology Systems, as well as senior financial roles at Biogen and Millennium Pharmaceuticals.

16th August 2013

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...